Capstone Quarterly Balance Sheet
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capstone financial position
As of Sep 30, 2026, Capstone reported total assets of $56.9 million, down 2.8% from a year earlier against total liabilities of $43.3 million. Shareholders' equity stood at $13.5 million, or 23.8% of assets. The company held $574,000 in cash and equivalents against $12.6 million of debt, a net debt position of $12.0 million.
The current ratio (current assets divided by current liabilities) was 1.04, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.93.
Summary generated from market data by MetaCap's automated system. Methodology
Capstone balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 574.00K | 225.00K | 419.00K | 727.00K | 730.00K | 773.00K | 1.74M | 11.00K | 13.00K | — | 30.00K | 52.00K |
| Receivables | 9.69M | 9.38M | 6.90M | 4.86M | 5.77M | 5.49M | 4.52M | 2.76M | — | — | — | 2.58M |
| Inventory | 16.32M | 16.39M | 18.06M | 17.06M | 12.17M | 9.59M | 9.78M | 9.63M | — | — | — | 13.75M |
| Total Current Assets | 27.53M | 26.86M | 25.98M | 23.00M | 19.11M | 16.53M | 16.71M | 12.80M | — | — | — | 17.08M |
| Property, Plant & Equipment | 1.95M | 1.96M | 2.00M | 2.08M | 1.70M | 1.47M | 1.53M | 1.59M | — | — | — | 1.76M |
| Goodwill | 18.48M | 18.48M | 18.46M | 18.46M | 26.03M | 23.29M | 23.29M | 23.29M | — | — | — | 23.29M |
| Intangible Assets | 1.73M | 1.76M | 1.81M | 1.84M | 359.00K | 61.00K | — | 48.00K | — | — | — | — |
| Total Assets | 56.85M | 54.68M | 53.80M | 51.38M | 58.48M | 51.88M | 52.21M | 47.22M | — | — | — | 52.70M |
| Accounts Payable | — | — | — | — | 5.48M | 3.60M | 4.38M | 3.30M | — | — | — | 2.58M |
| Short-Term Debt | 3.88M | 4.25M | 4.39M | 3.71M | 3.72M | 2.91M | 973.00K | 1.85M | — | — | — | 3.61M |
| Total Current Liabilities | 26.40M | 27.11M | 27.43M | 22.90M | 20.02M | 16.97M | 14.66M | 12.55M | — | — | — | 15.97M |
| Long-Term Debt | 8.70M | 8.60M | 8.79M | 9.34M | 7.23M | 5.83M | 7.54M | 6.32M | — | — | — | 5.11M |
| Total Liabilities | 43.34M | 42.26M | 42.57M | 38.92M | 31.33M | 25.61M | 25.24M | 20.66M | — | — | — | 23.58M |
| Shareholders' Equity | 13.52M | 12.42M | 11.22M | 12.45M | 25.22M | 26.27M | 26.97M | -3.06M | -1.92M | -925.00K | 403.00K | 2.44M |
| Retained Earnings | -221.96M | -221.33M | -219.95M | -218.04M | -201.25M | -199.24M | -198.53M | -196.10M | — | — | — | -190.61M |
| Total Debt | 12.59M | 12.85M | 13.18M | 13.05M | 10.95M | 8.74M | 8.51M | 8.18M | — | — | — | 8.73M |
| Net Cash (Debt) | -12.01M | -12.62M | -12.76M | -12.32M | -10.22M | -7.96M | -6.77M | -8.17M | 13.00K | — | 30.00K | -8.67M |
| Shares Outstanding | 911.17K | 15.20M | 9.43M | 8.77M | — | — | — | — | — | — | — | — |
This table shows 12 quarterly periods of Capstone's balance sheet, from Q3 2026 back to Q4 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a balance sheet?